Přehled o publikaci
2023
16S rRNA gene primer choice impacts off-target amplification in human gastrointestinal tract biopsies and microbiome profiling
DEISSOVÁ, Tereza; Martina ZAPLETALOVÁ; Lumír KUNOVSKÝ; Radek KROUPA; Tomáš GROLICH et al.Basic information
Original name
16S rRNA gene primer choice impacts off-target amplification in human gastrointestinal tract biopsies and microbiome profiling
Authors
DEISSOVÁ, Tereza; Martina ZAPLETALOVÁ; Lumír KUNOVSKÝ; Radek KROUPA; Tomáš GROLICH; Zdeněk KALA; Petra BOŘILOVÁ LINHARTOVÁ and Jan LOCHMAN
Edition
SCIENTIFIC REPORTS, England, NATURE PORTFOLIO, 2023, 2045-2322
Other information
Language
English
Type of outcome
Article in a journal
Country of publisher
Germany
Confidentiality degree
is not subject to a state or trade secret
References:
Marked to be transferred to RIV
Yes
RIV identification code
RIV/00216224:14110/23:00132245
Organization
Lékařská fakulta – Repository – Repository
UT WoS
EID Scopus
Keywords in English
ESOPHAGEAL MICROBIOTA; REVEALS; SAMPLE
Links
EF17_043/0009632, research and development project. LM2018140, research and development project. NU20-03-00126, research and development project. 857560, interní kód Repo. RECETOX RI, large research infrastructures. NCMG II, large research infrastructures.
Changed: 16/10/2024 00:50, RNDr. Daniel Jakubík
Abstract
In the original language
16S rRNA amplicon sequencing or, more recently, metatranscriptomic analysis are currently the only preferred methods for microbial profiling of samples containing a predominant ratio of human to bacterial DNA. However, due to the off-target amplification of human DNA, current protocols are inadequate for bioptic samples. Here we present an efficient, reliable, and affordable method for the bacteriome analysis of clinical samples human DNA content predominates. We determined the microbiota profile in a total of 40 human biopsies of the esophagus, stomach, and duodenum using 16S rRNA amplicon sequencing with the widely used 515F-806R (V4) primers targeting the V4 region, 68F-338R primers and a modified set of 68F-338R (V1-V2M) primers targeting the V1-V2 region. With the V4 primers, on average 70% of amplicon sequence variants (ASV) mapped to the human genome. On the other hand, this off-target amplification was absent when using the V1-V2M primers. Moreover, the V1-V2M primers provided significantly higher taxonomic richness and reproducibility of analysis compared to the V4 primers. We conclude that the V1-V2M 16S rRNA sequencing method is reliable, cost-effective, and applicable for low-bacterial abundant human samples in medical research.